Success of NDS' Cardio Cuts®Drives New Product Growth for Bond Labs
OMAHA, Neb.--(BUSINESS WIRE)-- Bond Laboratories, Inc. (OTCBB:BNLB) ("Bond Labs"), an international provider of innovative and proprietary nutritional supplements for health conscious consumers, marketed primarily through its wholly owned operating division, NDS Nutrition Products ("NDS"), (www.ndsnutrition.com) is pleased to announce that, due to its tremendous sales success and customer popularity, the Company is once again expanding on its top selling line of Cardio Cuts® pre-workout drinks.
Cardio Cuts®, a creatine free, thermogenic, pre-workout drink that provides maximum energy with a fat burning boost to deliver powerful results, was originally introduced at the annual GNC® franchisee convention in July of 2011. The immediate success of Cardio Cuts® prompted the Company to introduce two new flavors, black cherry and green apple, to add to its top selling strawberry.
"Cardio Cuts® has been extremely well received by franchise owners and customers already loyal to the NDS brand," stated John S. Wilson, Bond Labs' Chief Executive Officer. "Seeking to build further on that remarkable popularity, NDS is introducing two new flavors to add to this successful product line. Cardio Cuts® is now available in delicious raspberry lemonade and grape."
"Bond's revenue growth is dependent on new product innovation," continued Mr. Wilson. "New product innovation remains an integral part of our ongoing growth strategy and NDS has a long-standing tradition of developing high-quality dietary and nutritional supplements. We are thrilled to introduce these two new products into the multi-billion dollar sports nutrition and weight-loss categories," concluded Mr. Wilson.
About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through NDS Nutrition Products ("NDS"), a wholly owned operating division. NDS sells over 50 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health exclusively to GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Company's pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company's filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Surety Financial Group, LLC
Bruce Weinstein, 410-833-0078
KEYWORDS: United States North America Nebraska
The article Success of NDS' Cardio Cuts® Drives New Product Growth for Bond Labs originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.